Y iv0rc.J. ; a8inka.M. ; Zvara,V. ; Dut3ek.J. ' Faculty o? Pediatric8,Charlea Univeraity, poetgra#ua-te Medical Institute, Department of Urology,Komensky8e Univeraity, Praha,Bratielava, Czechoelovakia An enquiry campaign waa ueed to determine the frequency of chronic renal inaufficiency in children aged 0-15 yeare in the territory of Czechoslovakia. The prevalence(tota1 frequency) was 3,6/mill. inhabitante, the incidence(annua1 increase) wee 116/mill. inhabitante. Hereditary and congenital affectlone were the cauee of renal ineufficiency in 75,9% of caeee, acquired affection8 in 24,1% of caaee. Of the latter, the moat fre~uent cause wae chronic glomerulonephritie, which participated in the total number of caueee vith 16,7%. The higheet number of child ren was in the group 11-15 yeare 01d(57,4%). The authore compare obtained data to the data in literatuTe; they present a project with the aim to eneure radical therapy of children with chronic renal failure by ueing exleting dialysie centers for adults including 2-3 centre intended merely for children; of the latter, 1-2 muet be built up. They also propose the eetabliehment of a central regieter for all children with chronic renal inaufficiency living in Czechoslovakia.
A DECISION-MAKING MODEL FOR TREATMENT CHOICE OF ESRD
230 IN CHILDREN. m, =. , Richardson, E., Regional Nephrology Program. Hamilton, Ontario, Canada. Decisions concernina the modalitv of choice for children with ESRD are not made In a random fashion. Intuition, technical expertise, past experiences and enthusiasm for new modalities color one's perception of the optimal treatment choice. We propose a framework where treatment alternatives are examined systematically. A feasibility equation for the treatment of choice has been developed which scores 4 variables: quality of life, medical factors, transplantability and management issues. Scores are then tabulated for treatment choice. The model was used to examine 19 children ages 6 wks.-16 yrs. over 10 yrs. Flve pts. whom the authors had no input in decision-making were examined retrospectively, 1 1 were scored retrospectively where the authors decided the modality and 3 pts. were studied prospectively. Twenty four decisions were audited. Early pts. had only 3 possible dialysis alternatives, centre peritoneal, centre hemo. and home hemo., whereas the more recent pts. had the additional choices of home peritoneal cycler, continuous ambulatory peritoneal and self-care hem. We believe that this model can be helpful at different points in time. initially it encourages a review of all possible treatment choice. Later it may be used as an ongoing assessment tool pointing to other alternatives as m r e information is gathered and thus minimize the need for decision-making at the time of a crisis. Finally, it serves as a tool to choose other modes of dialysis after the treatment of choice fails.
SOCIOLOGICAL ASPECTS OF CONFLICTS IN A DIALYSIS

CENTER BETWEEN THE PHYSICIANS AND THE PARENTS OF CHILDREN IN THE TERMINAL RENAL FAILURE STAGE OF CHRONIC KIDNEY DISEASE.
Two main problems arise when alloting roles to parents and to physicians. On one hand the diet that the sick child should strictly follow in order to survive, which is differently interpreted by the parents according to their cultural, religious and social background and whether they come from the town or from the country. On the other the child'sattendance at school, which is highly recommended by the research physician who is concerned with the socialization of the patient-subject.
I spent two years at "Les Enfants-Malades", a children's hospital in Paris, in a dialysis center where the patients are dialyzed several times a week. The methods I used consisted in participant observation, interwievinq doctors, nurses in the unit. I also attended once a week for six months the consultations dealing with the children who had received transplants.
The problematics regarding this illness are linked to a broader issue : the socialization of non reducible handicaps. The pathogenesis of the anemia of chronic renal failure is multifactorial. Anabolic steroid has been reported to be of therapeutic value, but it is difficult to use because of its side effect especially in children. We used an analog of activated vitamin D (la-OH-D3) in 6 haemodialysis patients with anemia. After la-OH-D3 treatment, hemoglobin and hematocrit values didn't change in these patients, but frequency of blood transfusion has been decreased.
INTEGRATION OF CHILDREN AND ADOLESCENTS AT DIFFERENT
We examined serum erythropoietin by in vitro bioassay and haemoaggulutination inhibition assay. And we also examined the effect of various vitamin D metabolites on in vitro growth of granulopoietic and erythropoietic colonies.
la-OH-D3 is suspected to have anabolic steroid like effect.
FINAL HEIGHT OF CHILDREN WITH CHRONIC RENAL
FAILURE (CRF)
Gllli,G., Mehls,O., Fischer,W., Scharer,K. University Children's Hospital, Heidelberg, F.R.G.
It is well known that CRF retards body growth and skeletal maturation. However, neither the relationship between growth retardation and attainment of adult height has been ascertained nor it is known at what age children with CRF cease to grow. The present study is based upon evaluation of 34 children followed 3-9 yrs after onset on CRF up to the time of epiphyseal union of the hand and wrist bones and minimal (< 1 cmjyr) or no growth since at least 1 year. 23 pts had congenital(A) and 1 1 acquired(B) nephropathies. Final height was attained at the average age of 18.3 yrs in males and 16.9 yrs in females. Mean final height was well below the 50th centile in both groups with no statistical difference between males and females. 7 pts(30%) in group A hut only 1 in group B reached a final height< 3rd centile. There was no difference among the two groups regarding medical treatment, dietary intake and duration of dialysis, but age at first symptoms and age at onset of CRF differed significantly. It is suggested that primary renal disease and duration of CRF are major factors causing reduction of adult height in children with CRF.
